Work

Engineered Exosomes Delivering FOSB siRNA Alleviate Podocyte Injury in Hepatitis B Virus-Associated Nephritis

Year: 2026
Type: preprint
Abstract: Hepatitis B virus-associated glomerulonephritis (HBV-GN) is the common extrahepatic manifestation of HBV infection and a major secondary glomerular disease in China. Upregulated FOSB mediates podocyte injury induced by HBx, whereas silencing FOSB can reverse this pathological change. Bone marrow mesenchymal stem cell-derived exosomes (BMSC-Exos) exhibit excellent biocompatibility, while their clinical application is limited by short circulating half-life and insufficient drug loading capacity. Herein, we constructed Cyclo(RGDfC)-modified BMSC-Exos encapsulated with FOSB siRNA and investigated its therapeutic potential against HBx-mediated podocyte damage. Transcriptomic analysis of renal samples from HBV-GN patients and healthy volunteers screened FOSB as a key pathogenic gene. We established an in vitro HBx-overexpressing podocyte model and an in vivo HBx transgenic mouse model. Engineered exosomes were prepared via covalent coupling of Cyclo(RGDfC) and siRNA loading, followed by comprehensive characterization. Our data verified that HBx induced FOSB overexpression. Cyclo(RGDfC)-modified engineered exosomes can be internalized by podocytes. Relative to unmodified exosomes, these constructs significantly downregulated FOSB, alleviated podocyte apoptosis and inflammatory response, and ameliorated renal lesions and dysfunction in transgenic mice. Collectively, Cyclo(RGDfC)-modified FOSB siRNA-loaded BMSC-Exos hinder HBV-GN progression through inhibiting FOSB-dependent podocyte injury, which represents a prospective therapeutic strategy for HBV-GN.
Language: English
Open Access status: green
OpenAlex ID: W7236663448
Cites: 56
Cited by:
Related to: 10